SELL, ITGB4, ALDH3B1, THBS4, and ADH4 were predicted to be protective factors of HCC, while UGT2B17, NAT2, FABP3, CDH2, ACSL5, and ADH6 were forecasted as risk factors of HCC (Table S2). This evidence concerns the gene SELL and hepatocellular carcinoma.